Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Respiratory Volumes and Capacities I01:26

Respiratory Volumes and Capacities I

2.0K
Assessing the respiratory rate and rhythm for a complete minute is crucial for evaluating the breathing pattern. Even a minor increase in the patient's average respiratory rate, by as little as three to five breaths per minute, is an early and vital indicator of respiratory distress. Patients with a respiratory rate exceeding twenty-four breaths per minute require close monitoring to determine the physiological alterations. This careful observation is essential for prompt recognition and...
2.0K
Respiratory Volumes01:15

Respiratory Volumes

3.1K
Respiratory volumes are crucial metrics, meticulously measured to quantify the air exchanged in and out of the lungs during various phases of the breathing cycle. These precise measurements are vital for assessing lung function, diagnosing respiratory conditions, and monitoring overall respiratory health. Each parameter provides specific insights into the mechanics of breathing and the functional capacity of the lungs.
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
3.1K
Respiratory Capacities01:24

Respiratory Capacities

1.4K
Respiratory capacities are crucial indicators of lung function, representing the maximum amount of air an individual's respiratory system can handle during various breathing phases.
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
1.4K
Common Respiratory Disorders01:31

Common Respiratory Disorders

1.8K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.8K
Respiratory Volumes and Capacities01:22

Respiratory Volumes and Capacities

7.6K
The respiratory system is responsible for the intake of oxygen and the expulsion of carbon dioxide from the body. Respiratory volumes describe the volume of air in the lungs at different phases of the respiratory cycle. Tidal volume is the air breathed in and out during normal, quiet breathing. Inspiratory reserve volume is the air that can be forcefully inspired beyond the tidal volume. In contrast, expiratory reserve volume refers to the air that can be expelled from the lungs after a normal...
7.6K
Influenza01:27

Influenza

87
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
87

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The New Vaccine Surveillance Network: 25 years of active, population-based surveillance for pediatric infectious diseases in the United States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Correlations and Timeliness of Respiratory Syncytial Virus Surveillance Indicators-United States, 2018-2024.

Influenza and other respiratory viruses·2026
Same author

Evaluating Analytic Approaches to Determining Respiratory Syncytial Virus Seasonality-United States, 2014-2024.

Influenza and other respiratory viruses·2026
Same author

Hemagglutination-inhibition and microneutralization antibody titers as mediators of protection for cell-based and recombinant influenza vaccines.

NPJ vaccines·2026
Same author

Comparative evaluation of SARS-CoV-2 laboratory testing data sources for U.S. COVID-19 public health surveillance, 2020-2024.

Frontiers in public health·2026
Same author

Evolutionary dynamics of Respiratory Syncytial Virus in pre-pandemic, pandemic, and post-pandemic periods in Houston, Texas, USA.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 5, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 11, 2013

7.6K

Respiratory Virus Activity - United States, July 1, 2024-June 30, 2025.

Benjamin J Silk, Mila M Prill, Amber K Winn

    MMWR. Morbidity and Mortality Weekly Report
    |February 19, 2026
    PubMed
    Summary

    National surveillance tracked respiratory viruses like SARS-CoV-2 and RSV from July 2024-June 2025. Vaccination remains crucial for preventing severe illness from these common respiratory pathogens.

    More Related Videos

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    10.6K
    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
    11:48

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

    Published on: April 4, 2019

    16.3K

    Related Experiment Videos

    Last Updated: May 5, 2026

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
    09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 11, 2013

    7.6K
    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    10.6K
    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
    11:48

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

    Published on: April 4, 2019

    16.3K

    Area of Science:

    • Public Health
    • Epidemiology
    • Virology

    Background:

    • Respiratory viruses cause significant illness, hospitalizations, and deaths annually.
    • The Centers for Disease Control and Prevention (CDC) employs multiple surveillance systems to monitor respiratory virus activity.
    • Understanding seasonal trends and population impact is vital for public health interventions.

    Purpose of the Study:

    • To summarize U.S. trends in endemic respiratory virus activity from July 2024 to June 2025.
    • To describe national and regional trends, hospitalization rates, and mortality for SARS-CoV-2 and Respiratory Syncytial Virus (RSV).
    • To provide preliminary estimates of illnesses, outpatient visits, hospitalizations, and deaths associated with these viruses.

    Main Methods:

    • National surveillance data collection and analysis.
    • Monitoring of laboratory test results, hospitalization rates, and vital records.
    • Genetic characterization of circulating SARS-CoV-2 viruses.

    Main Results:

    • SARS-CoV-2 exhibited bimodal peaks, while RSV and influenza showed single peaks.
    • Highest COVID-19 hospitalization rates were among adults aged ≥75 years and infants <6 months.
    • RSV hospitalization rates were highest in infants <12 months and adults ≥75 years.
    • Estimated 290,000-450,000 COVID-19 hospitalizations and 190,000-350,000 RSV hospitalizations occurred.
    • Circulating SARS-CoV-2 lineages were descendants of Omicron JN.1.

    Conclusions:

    • Staying current with COVID-19, RSV, and influenza vaccinations is essential for reducing severe disease.
    • Surveillance data highlights vulnerable populations for severe outcomes.
    • Continued monitoring of respiratory viruses is necessary for informed public health strategies.